Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis

(2014) K. Metcalfe et al.   BMJ-British Medical Journal

A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive Italian women

(2013) L. Cortesi et al.   ANNALS OF ONCOLOGY

Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer

(2013) D. Gareth R. Evans et al.   BREAST CANCER RESEARCH AND TREATMENT

Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

(2013) Richard M Brohet et al.   JOURNAL OF MEDICAL GENETICS

Contralateral risk-reducing mastectomy in sporadic breast cancer

(2013) John A Murphy et al.   LANCET ONCOLOGY

Comparison of Patient Characteristics and Outcomes of Contralateral Prophylactic Mastectomy and Unilateral Total Mastectomy in Breast Cancer Patients

(2012) Alice Chung et al.   ANNALS OF SURGICAL ONCOLOGY

How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer

(2012) Kaaren J Watts et al.   BMC CANCER

Risk of Asynchronous Contralateral Breast Cancer in Noncarriers ofBRCA1andBRCA2Mutations With a Family History of Breast Cancer: A Report From the Women's Environmental Cancer and Radiation Epidemiology Study

(2012) Anne S. Reiner et al.   JOURNAL OF CLINICAL ONCOLOGY

Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations

(2011) Marissa Howard-McNatt et al.   AMERICAN JOURNAL OF SURGERY

Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: Design of a multicenter randomized clinical trial

(2011) Marijke R Wevers et al.   BMC CANCER

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

(2011) K Metcalfe et al.   BRITISH JOURNAL OF CANCER

Clinical Management Factors Contribute to the Decision for Contralateral Prophylactic Mastectomy

(2011) Tari A. King et al.   JOURNAL OF CLINICAL ONCOLOGY

Increase in Contralateral Prophylactic Mastectomy: Echoes of a Bygone Era?

(2010) Chee-Chee H. Stucky et al.   ANNALS OF SURGICAL ONCOLOGY

Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age

(2010) Dorina M. van der Kolk et al.   BREAST CANCER RESEARCH AND TREATMENT

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy

(2010) A Fuchsia Howard et al.   BMC Womens Health

Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)

(2009) Belinda E. Kiely et al.   BREAST CANCER RESEARCH AND TREATMENT

Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers

(2009) Anouk Pijpe et al.   BREAST CANCER RESEARCH AND TREATMENT

BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing

(2009) E. VAN RIEL et al.   EUROPEAN JOURNAL OF CANCER CARE

Uptake, Time Course, and Predictors of Risk-Reducing Surgeries in BRCA Carriers

(2009) Mary S. Beattie et al.   Genetic Testing and Molecular Biomarkers

Contralateral Risk-Reducing Mastectomy in Young Breast Cancer Patients with and without Genetic Cancer Risk Assessment

(2008) Phuong L. Mai et al.   ANNALS OF SURGICAL ONCOLOGY

Predictors of Contralateral Prophylactic Mastectomy in Women With a BRCA1 or BRCA2 Mutation: The Hereditary Breast Cancer Clinical Study Group

(2008) Kelly A. Metcalfe et al.   JOURNAL OF CLINICAL ONCOLOGY